The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
Open accessAbstract
Recent data implicates a role for the CD40–CD40 ligand (CD40L) pathway in graft rejection. One potential mechanism is direct costimulation of T cells through CD40L. Alternatively, the ability of CD40 stimulation to induce CD80 (B7-1) and CD86 (B7-2) expression on antigen-presenting cells (APCs) has led to the hypothesis that the role of CD40–CD40L interactions in transplant rejection might be indirect, i.e., to promote the costimulatory capacity of APCs. Here, we have used a murine vascularized cardiac allograft model to test this hypothesis. Treatment of the recipients with donor splenocytes and a single dose of anti-CD40L mAb induces long-term graft survival (>100 days) in all animals. This is associated with marked inhibition of intragraft Th1 cytokine [interferon γ and interleukin (IL) 2] and IL-12 expression with reciprocal up-regulation of Th2 cytokines (IL-4 and IL-10). In untreated allograft recipients, CD86 is strongly expressed on endothelial cells and infiltrating mononuclear cells of the graft within 24 hr. In contrast, CD80 expression is not seen until 72 hr after engraftment. Anti-CD40L mAb has no detectable effect on CD86 up-regulation, but almost completely abolishes induction of CD80. However, animals treated with anti-CD80 mAb or with a mutated form of CTLA4Ig (which does not bind to CD86) rejected their cardiac allografts, indicating that blockade of CD80 alone does not mediate the graft-prolonging effects of anti-CD40L mAb. These data support the notion that the role of CD40–CD40L in transplant rejection is not solely to promote CD80 or CD86 expression, but rather that this pathway can directly and independently costimulate T cells. These data also suggest that long-term graft survival can be achieved without blockade of either T cell receptor-mediated signals or CD28–CD86 engagement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Self-citationLong-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., et al. (1996) · Nature · doi:10.1038/381434a0 · Cited by 1,455
Self-citationThe B7 and CD28 receptor families
June, C. H., Bluestone, J. A., Nadler, L. M., & Thompson, C. B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90080-9 · Cited by 1,296
Signals and signs for lymphocyte responses
Janeway, C. A., & Bottomly, K. (1994) · Cell · doi:10.1016/0092-8674(94)90335-2 · Cited by 848
Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6550 · Cited by 804
CORRY, R. J., WINN, H. J., & RUSSELL, P. S. (1973) · Transplantation · doi:10.1097/00007890-197310000-00010 · Cited by 785
Ranheim, E. A., & Kipps, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.925 · Cited by 580
Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C., & Spriggs, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.669 · Cited by 578
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
Sayegh, M. H., Akalin, E., Hancock, W. W., Russell, M. E., Carpenter, C. B., Linsley, P. S., & Turka, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1869 · Cited by 511
Self-citationLin, H., Bolling, S. F., Linsley, P. S., Wei, R. Q., Gordon, D., Thompson, C. B., & Turka, L. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1801 · Cited by 485
Self-citationAcquisition of immunologic self-tolerance
Schwartz, R. H. (1989) · Cell · doi:10.1016/0092-8674(89)90044-5 · Cited by 477
Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., & Pober, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4342 · Cited by 472
Parker, D. C., Greiner, D. L., Phillips, N. E., Appel, M. C., Steele, A. W., Durie, F. H., Noelle, R. J., Mordes, J. P., & Rossini, A. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9560 · Cited by 411
Expression of functional CD40 by vascular endothelial cells.
Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A., & Aruffo, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.33 · Cited by 411
CD40 ligand-transduced co-stimulation of T cells in the development of helper function
Essen, D. V., Kikutani, H., & Gray, D. (1995) · Nature · doi:10.1038/378620a0 · Cited by 409
The role of CD40 in the regulation of humoral and cell-mediated immunity
Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., & Noelle, R. J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90269-0 · Cited by 373
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
Guinan, E., Gribben, J., Boussiotis, V., Freeman, G., & Nadler, L. (1994) · Blood · doi:10.1182/blood.v84.10.3261.3261 · Cited by 358
Stuber, E., Strober, W., & Neurath, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.693 · Cited by 338
Larsen, C. P., Alexander, D. Z., Hollenbaugh, D., Elwood, E. T., Ritchie, S. C., Aruffo, A., Hendrix, R., & Pearson, T. C. (1996) · Transplantation · doi:10.1097/00007890-199601150-00002 · Cited by 323
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
Miller, S. D., Vanderlugt, C. L., Lenschow, D. J., Pope, J. G., Karandikar, N. J., Dal Canto, M. C., & Bluestone, J. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90063-2 · Cited by 315
TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1
Pearson, T. C., Alexander, D. Z., Winn, K. J., Linsley, P. S., Lowry, R. P., & Larsen, C. P. (1994) · Transplantation · doi:10.1097/00007890-199406270-00002 · Cited by 298
Self-citationTRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1
Pearson, T. C., Alexander, D. Z., Winn, K. J., Linsley, P. S., Lowry, R. P., & Larsen, C. P. (1994) · Transplantation · doi:10.1097/00007890-199457120-00002 · Cited by 295
Self-citationFunctional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Szabolcs, M., Stern, D., & Chess, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1857 · Cited by 273
CD40 preferentially costimulates activation of CD4+ T lymphocytes.
Cayabyab, M., Phillips, J. H., & Lanier, L. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1523 · Cited by 241
Roy, M., Aruffo, A., Ledbetter, J., Linsley, P., Kehry, M., & Noelle, R. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250243 · Cited by 214
Self-citationRazi-Wolf, Z., Freeman, G. J., Galvin, F., Benacerraf, B., Nadler, L., & Reiser, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4210 · Cited by 210
Durie, F. H., Aruffo, A., Ledbetter, J., Crassi, K. M., Green, W. R., Fast, L. D., & Noelle, R. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117453 · Cited by 180
Hancock, W. W., Polanski, M., Zhang, J., BLOGG, N. S., & Weiner, H. L. (1995) · Europe PMC (PubMed Central) · Cited by 161
Self-citationINHIBITION OF TRANSPLANT REJECTION FOLLOWING TREATMENT WITH ANTI-B7-2 AND ANTI-B7-1 ANTIBODIES
Lenschow, D. J., Zeng, Y., Hathcock, K. S., Zuckerman, L. A., Freeman, G., Thistlethwaite, J. R., Gray, G. S., Hodes, R. J., & Bluestone, J. A. (1995) · Transplantation · doi:10.1097/00007890-199511270-00019 · Cited by 160
Tian, L., Noelle, R. J., & Lawrence, D. A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250152 · Cited by 134
Khoury, S. J., Gallon, L. G., Verburg, R. R., Chandraker, A. K., Peach, R., Linsley, P. S., Turka, L. A., Hancock, W. W., & Sayegh, M. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3700 · Cited by 73
Self-citationSayegh, M. H., & Turka, L. A. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641143 · Cited by 72
Self-citation
Cited by
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
Hancock, W. W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J. A., Smiley, S. T., Ling, M., Gerard, N. P., & Gerard, C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1515 · Cited by 617
Self-citationThe immunologic basis for the treatment of psoriasis with new biologic agents
Krueger, J. G. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120568 · Cited by 600
Metadata
- Authors
- Hancock, W. W., Sayegh, M. H., Zheng, X.-G., Peach, R., Linsley, P. S., & Turka, L. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-11-26
- Volume
- 93
- Issue
- 24
- Pages
- 13967-13972
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2035455050
- Cited by
- 411
- References
- 32
- FWCI
- 29.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.